These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17053437)

  • 21. [Should Helicobacter pylori infection be taken into account in the use of nonsteroidal anti-inflammatory agents?].
    Bretagne JF; Pagenault M; Bourienne A; Heresbach D
    Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C48-64. PubMed ID: 10880915
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chemotherapy and NSAIDs in neoplastic disease. Role of anti-secretory preventive therapy].
    Annibale B; Panzuto F
    Recenti Prog Med; 2003 Nov; 94(11):473-7. PubMed ID: 14679914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
    Zakharova NV
    Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
    [No Abstract]   [Full Text] [Related]  

  • 25. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Lanas A; Scheiman J
    Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of psychosocial factors in peptic ulcer disease: beyond Helicobacter pylori and NSAIDs.
    Jones MP
    J Psychosom Res; 2006 Apr; 60(4):407-12. PubMed ID: 16581366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in peptic ulcer between the East and the West.
    Leong RW
    Gastroenterol Clin North Am; 2009 Jun; 38(2):363-79. PubMed ID: 19446264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori and non-malignant diseases.
    Furuta T; Delchier JC
    Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
    Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.
    Tseng GY; Lin HJ; Fang CT; Yang HB; Tseng GC; Wang PC; Hung TL; Deng YC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2007 Sep; 26(6):925-33. PubMed ID: 17767477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
    Chen JT; Pucino F; Resman-Targoff BH
    J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.
    Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I
    Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
    Kiltz U; Zochling J; Schmidt WE; Braun J
    Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-steroidal anti-inflammatory drugs request parity with Helicobacter pylori.
    Ladwa M; Takeuchi K; Bjarnason I
    Scand J Gastroenterol; 2006 Apr; 41(4):373-5. PubMed ID: 16635902
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of aspirin-induced gastroduodenal damage: H. pylori infection eradication versus proton pump inhibitors or both.
    Lanas A
    Dig Liver Dis; 2004 Oct; 36(10):655-7. PubMed ID: 15506662
    [No Abstract]   [Full Text] [Related]  

  • 39. Review article: acid-related disease--what are the unmet clinical needs?
    Katz PO; Scheiman JM; Barkun AN
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():9-22. PubMed ID: 16700899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.
    Qasim A; O'Morain CA; O'Connor HJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):43-52. PubMed ID: 19207543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.